Opocrin Group is engaged in pharmaceutical research and development, production and commercialization of active ingredients and new therapeutic solutions. From active ingredient to specialty pharmaceutical, work ethic and passion have led us to be global market leader in the heparin derivatives market. But this is only the beginning. We reason as innovators, we work with expertise and dedication, we produce together people who care about people. Putting the power of science at the service of life. Fully paid-up share capital € 3,000,000.00 Fiscal Code / VAT No. / Companies House of Modena No. 00156140360
| Website | https://opocringroup.it/ |
| Employees | 208 (129 on RocketReach) |
| Founded | 1964 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Active Pharmaceutical Ingredients, Pharmaceutical Research, Therapeutic Solutions, Drug Development, Pharmaceutical Production, Api Manufacturing, Drug Manufacturing, New Drug Development, Drug Commercialization, Pharmaceutical Commercialization, Pharmaceutical Ingredients, Specialty Pharmaceuticals, Biopharmaceutical, Clinical Trials, Prescription Drugs, Pharma, Healthcare, Medicine, Over The Counter Drugs, Generic Drugs |
| Competitors | Johnson & Johnson, Novartis, Sanofi, Boehringer Ingelheim, Merck Group, Eisai Co., Ltd., Bausch Health Companies Inc., Alfasigma, Zambon, SIFI +52 more (view full list) |
Looking for a particular OPOCRIN GROUP employee's phone or email?
Giovanni Caglio is the Chief Commercial Officer of OPOCRIN GROUP.
129 people are employed at OPOCRIN GROUP.